President and Chief Executive Officer
Emory has over 32 years of experience in the healthcare, consumer electronics, and data communications industries. He joined Intuity Medical as the President and Chief Executive Officer in September 2008. Prior to Intuity Medical, Emory served as President and Chief Executive Officer of Adeza Biomedical, a public company focusing on women’s reproductive healthcare. At Adeza, Emory led the company to a successful IPO in 2004 and eventual acquisition by Cytyc in 2007. Before Adeza, Emory served as Executive Vice President and Chief Operating Officer of Indesys, a data communications company, which he co-founded in 1984. Previously, he held the position of Director of Finance for Atari, in the Consumer Electronics Division.
Chief Commercial Officer – Senior Vice President of Sales and Marketing
Tim joined Intuity Medical in February 2018 with more than 26 years of experience in the pharmaceutical industry, serving in numerous roles in both the prescription (Rx) and over-the-counter (OTC) space. Prior to Intuity, Tim served as Vice President of Consumer Health for AmerisourceBergen, a leading global pharmaceutical sourcing and distribution services company, serving in that role since October 2011. Before AmerisourceBergen, Tim spent more than nine years operating in several senior level sales roles for Adams Respiratory Therapeutics as part of a team responsible for the commercialization of Mucinex®. Adams completed a successful IPO in 2005 and was acquired by Reckitt Benckiser Group in 2008. Previously, Tim worked for various pharmaceutical manufacturers in sales and marketing leadership roles.
Chief Financial Officer – Senior Vice President of Finance and Human Resources
Tammy joined Intuity Medical in July 2018 with more than 23 years of accounting and commercial financial experience in the medical device, pharmaceutical, and laboratory tools industries for both public and private companies. Prior to joining Intuity, Tammy served as the Chief Financial Officer and Senior Vice President for Labcyte, a private, global laboratory tools company, from 2011 to 2018. Tammy also served as the Vice President of Finance at Depomed, a publicly-traded specialty pharmaceutical company, from 2007 to 2011. She was also controller at Adeza Biomedical Corporation and was instrumental in bringing about its IPO and subsequent sale to Cytyc Corporation. Tammy also held various management roles as Director of Finance and Administration and Director of Treasury and external reporting at both public and private medical device companies and was a member of Ernst & Young’s audit practice.